POTASSIUM PHOSPHATES 236 MG
POTASSIUM PHOSPHATE DIBASIC : 236 MG POTASSIUM PHOSPHATE MONOBASIC : 224 MG · DIN 00804789 · SANDOZ CANADA INCORPORATED
Health Canada status: MARKETED
What is POTASSIUM PHOSPHATES?
POTASSIUM PHOSPHATES 236 MG contains POTASSIUM PHOSPHATE DIBASIC : 236 MG POTASSIUM PHOSPHATE MONOBASIC : 224 MG. It is listed in the Health Canada Drug Product Database under DIN 00804789, held by SANDOZ CANADA INCORPORATED, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 06-Jul-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00804789 |
|---|---|
| Brand name | POTASSIUM PHOSPHATES |
| Generic / active ingredient | POTASSIUM PHOSPHATE DIBASIC : 236 MG POTASSIUM PHOSPHATE MONOBASIC : 224 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 236 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05XA06 POTASSIUM PHOS INCL COMB W/0TH POT. SALTS |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 06-Jul-2006 |
| Original market date | 1989-12-31 00:00:00 |
Is POTASSIUM PHOS INCL COMB W/0TH POT. SALTS in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code B05XA06 POTASSIUM PHOS INCL COMB W/0TH POT. SALTS. 3 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| POTASSIUM PHOSPHATE MONOBASIC INJECTION | 176 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00711306 |
| POTASSIUM PHOSPHATES INJECTION, USP | 224 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02139545 |
| POTASSIUM PHOSPHATE INJ 3MMP/ML | 224 MG | SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00351539 |
| POTASSIUM PHOSPHATES INJ | 224 MG | LIQUID | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | CANCELLED POST MARKET | DIN 01944878 |
Who else supplies POTASSIUM PHOS INCL COMB W/0TH POT. SALTS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. POTASSIUM PHOS INCL COMB W/0TH POT. SALTS appears in 158 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.